Skip to main content
Premium Trial:

Request an Annual Quote

Eurobio Scientific Acquires Diagnostic International Distribution

NEW YORK – Eurobio Scientific said Tuesday that it has signed a deal to acquire Diagnostic International Distribution of Italy as part of its plan to become a major player in Europe's diagnostics market.

Denis Fortier, deputy managing director of France-based Eurobio, said in a statement that the COVID-19 pandemic strengthened the company's finances and the acquisition of DID gives it access to the Italian market and will help accelerate the company's transition "from a mainly French player to an international player in diagnostics." The firm also acquired Belgium-based Biomedical Diagnostics in June 2022, and Netherlands-based Genome Diagnostics in August.

Financial and other terms of the deal were not disclosed. Eurobio said it expects the sale will be finalized within about 45 days.

Milan, Italy-based DID is a 26-employee firm that specializes in the distribution of in vitro diagnostic tests in Italy, especially microbiology reagents and instruments. The firm generated revenues of about €26.8 million in 2022. It supplies hospitals, private biology laboratories, and companies in veterinary, industrial, and nutrition markets, and it recently expanded into point-of-care product sales.

DID CEO Enrico Maffioli said in a statement that the deal with Eurobio "will allow us to continue our development throughout Italy, at a time when diagnostics is becoming an increasingly important part of our healthcare system."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.